Coral Laboratories Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Coral Laboratories Ltd is ₹ 459.8 as of 18 May 15:30 . The P/E Ratio of Coral Laboratories Ltd changed from 8.5 on March 2021 to 10.4 on March 2025 . This represents a CAGR of 4.12% over 5 yearsThe P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Coral Laboratories Ltd changed from ₹ 115.04 crore on March 2021 to ₹ 250.4 crore on March 2025 . This represents a CAGR of 16.83% over 5 yearsThe Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 174.33 crore on March 2021 to ₹ 144 crore on March 2025 . This represents a CAGR of -3.75% over 5 years The revenue of Coral Laboratories Ltd for the Dec '25 is ₹ 24.06 crore as compare to the Sep '25 revenue of ₹ 22.07 crore. This represent the growth of 9.02% The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 7.28 crore as compare to the Sep '25 revenue of ₹ 4.17 crore. This represent the growth of 74.58% The ebitda of Coral Laboratories Ltd for the Dec '25 is ₹ 4.38 crore as compare to the Sep '25 ebitda of ₹ 7.97 crore. This represent the decline of -45.04% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0.3 crore as compare to the Sep '25 ebitda of ₹ -2.79 crore. This represent the decline of -110% The net profit of Coral Laboratories Ltd changed from ₹ 8.8 crore to ₹ 2.78 crore over 7 quarters. This represents a CAGR of -48.24% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -5.17 crore to ₹ -3.13 crore over 7 quarters. This represents a CAGR of -24.93% The Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February, 1997.
It was promoted by Navin B Doshi of the DWD Group.
To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore.
It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004.
It started the commercial production at Dehradun Plant in September, 2006. Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

FAQs for the comparison of Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd

Which company has a larger market capitalization, Coral Laboratories Ltd or Krebs Biochemicals & Industries Ltd?

Market cap of Coral Laboratories Ltd is 164 Cr while Market cap of Krebs Biochemicals & Industries Ltd is 120 Cr

What are the key factors driving the stock performance of Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd?

The stock performance of Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd?

As of May 18, 2026, the Coral Laboratories Ltd stock price is INR ₹459.8. On the other hand, Krebs Biochemicals & Industries Ltd stock price is INR ₹55.71.

How do dividend payouts of Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd compare?

To compare the dividend payouts of Coral Laboratories Ltd and Krebs Biochemicals & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.